Baseline histologic activity predicted colectomy risk in ulcerative colitis treated with biologics, independent of clinical or endoscopic factors.
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
IBD and pregnancy require careful planning. Women with IBD can have healthy pregnancies by managing their condition with ...
The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...
Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...
Mefenamic acid, a common anti-inflammatory drug already approved for pain management, has been found to significantly reduce ...
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...
A recent study published in the journal Medicine has found a possible connection between low vitamin D levels and increased ...
A real-world study in adolescent and young adult patients with inflammatory bowel disease (IBD) found no significant ...
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Wrist-worn devices can predict imminent inflammatory and symptomatic inflammatory bowel disease flare-ups as far in advance ...
Multidisciplinary care is needed to ensure positive maternal and fetal health outcomes, especially in complex or high-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback